Updated
Updated · Grants Pass Tribune · Jul 13
GLP-1 Weight Loss Thins Foot Fat Pads, Triggering 'Ozempic Feet' in Some Patients
Updated
Updated · Grants Pass Tribune · Jul 13

GLP-1 Weight Loss Thins Foot Fat Pads, Triggering 'Ozempic Feet' in Some Patients

3 articles · Updated · Grants Pass Tribune · Jul 13

Summary

  • Medical specialists say some patients who lose significant weight on GLP-1 drugs develop thinner heel and forefoot fat pads, leaving feet bonier and sometimes painful.
  • The change is not a formal diagnosis or an Ozempic-specific side effect; doctors say similar fat-pad loss can follow any rapid or substantial weight loss, including bariatric surgery.
  • Reduced cushioning can make walking feel like stepping on bone or stones, increase calluses and shoe-fit problems, and in some cases alter gait enough to affect ankles, knees, hips or the lower back.
  • Doctors still stress that weight loss often improves overall foot health by cutting load on joints, and they advise protein intake, strength training, supportive shoes and podiatry care for persistent pain.
  • Research on how often GLP-1 users develop these changes remains limited, with physicians urging closer monitoring—especially for people with diabetes, who face higher risks of ulcers and pressure injuries.

Insights

Weight loss drugs are shrinking foot fat pads. Are new fat-grafting treatments a permanent solution for the pain?
Beyond 'Ozempic feet,' what other essential body cushioning is at risk from today's rapid weight loss methods?